Literature DB >> 22942392

Disulfide linkage engineering for improving biophysical properties of human VH domains.

Dae Young Kim1, Hiba Kandalaft, Wen Ding, Shannon Ryan, Henk van Faassen, Tomoko Hirama, Simon J Foote, Roger MacKenzie, Jamshid Tanha.   

Abstract

To enhance their therapeutic potential, human antibody heavy chain variable domains (V(H)s) would benefit from increased thermostability. The highly conserved disulfide linkage that connects Cys23 and Cys104 residues in the core of V(H) domains is crucial to their stability and function. It has previously been shown that the introduction of a second disulfide linkage can increase the thermostability of camelid heavy-chain antibody variable domains (V(H)Hs). Using four model domains we demonstrate that this strategy is also applicable to human V(H) domains. The introduced disulfide linkage, formed between Cys54 and Cys78 residues, increased the thermostability of V(H)s by 14-18°C. In addition, using a novel hexa-histidine capture technology, circular dichroism, turbidity, size exclusion chromatography and multiangle light scattering measurements, we demonstrate reduced V(H) aggregation in domains with the Cys54-Cys78 disulfide linkage. However, we also found that the engineered disulfide linkage caused conformational changes, as indicated by reduced binding of the V(H)s to protein A. This indicates that it may be prudent to use the synthetic V(H) libraries harboring the engineered disulfide linkage before screening for affinity reagents. Such strategies may increase the number of thermostable binders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22942392     DOI: 10.1093/protein/gzs055

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  16 in total

1.  The role of intra-domain disulfide bonds in heat-induced irreversible denaturation of camelid single domain VHH antibodies.

Authors:  Yoko Akazawa-Ogawa; Koichi Uegaki; Yoshihisa Hagihara
Journal:  J Biochem       Date:  2015-08-19       Impact factor: 3.387

Review 2.  Advances in Antibody Design.

Authors:  Kathryn E Tiller; Peter M Tessier
Journal:  Annu Rev Biomed Eng       Date:  2015-08-14       Impact factor: 9.590

3.  Evaluation of a noncanonical Cys40-Cys55 disulfide linkage for stabilization of single-domain antibodies.

Authors:  Dae Young Kim; Hiba Kandalaft; Greg Hussack; Shalini Raphael; Wen Ding; John F Kelly; Kevin A Henry; Jamshid Tanha
Journal:  Protein Sci       Date:  2019-03-14       Impact factor: 6.725

Review 4.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

5.  Heat-induced irreversible denaturation of the camelid single domain VHH antibody is governed by chemical modifications.

Authors:  Yoko Akazawa-Ogawa; Mizuki Takashima; Young-Ho Lee; Takahisa Ikegami; Yuji Goto; Koichi Uegaki; Yoshihisa Hagihara
Journal:  J Biol Chem       Date:  2014-04-16       Impact factor: 5.157

6.  Modification of the kinetic stability of immunoglobulin G by solvent additives.

Authors:  Jonas V Schaefer; Erik Sedlák; Florian Kast; Michal Nemergut; Andreas Plückthun
Journal:  MAbs       Date:  2018-04-25       Impact factor: 5.857

Review 7.  Recent mass spectrometry-based techniques and considerations for disulfide bond characterization in proteins.

Authors:  Jude C Lakbub; Joshua T Shipman; Heather Desaire
Journal:  Anal Bioanal Chem       Date:  2017-12-18       Impact factor: 4.142

8.  Fully Human VH Single Domains That Rival the Stability and Cleft Recognition of Camelid Antibodies.

Authors:  Romain Rouet; Kip Dudgeon; Mary Christie; David Langley; Daniel Christ
Journal:  J Biol Chem       Date:  2015-03-03       Impact factor: 5.157

9.  Evaluation of disulfide bond position to enhance the thermal stability of a highly stable single domain antibody.

Authors:  Dan Zabetakis; Mark A Olson; George P Anderson; Patricia M Legler; Ellen R Goldman
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

10.  Antibody light chain variable domains and their biophysically improved versions for human immunotherapy.

Authors:  Dae Young Kim; Rebecca To; Hiba Kandalaft; Wen Ding; Henk van Faassen; Yan Luo; Joseph D Schrag; Nadereh St-Amant; Mary Hefford; Tomoko Hirama; John F Kelly; Roger MacKenzie; Jamshid Tanha
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.